Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis

Hypertension

Volumn 36, Issue 4, 2000, Pages 638-641

  Arakawa, Kikuo ^a   Urata, Hidenori ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme; Atherosclerosis; Cardiovascular diseases; Kallikrein

Indexed keywords

ANGIOTENSIN; CHOLESTEROL; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; ENZYME INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL MODEL; ANIMAL TISSUE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; KALLIKREIN KININ SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0033770425     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.36.4.638     Document Type: Review

References (25)

1. Serine protease angiotensin II systems
2. A pressor formation by trypsin from renin-denatured human plasma protein
3. Ability of kallikrein to generate angiotensin II-like pressor substance and a proposed 'kinin-tensin enzyme system'
4. Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart
5. Beneficial effects of a serine protease inhibitor in peripheral vascular disease
6. Angiotensin II formation by an alternative pathway during exercise in humans
7. Differences in tissue angiotensin II-forming pathways by species and organs in vitro
8. Differential regulation of angiotensin II-forming enzymes by tissues in 2-kidney 1 clip hypertensive hamster
9. Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo
10. Mast cell chymase-like protease(s) modulates Escherichia coli lipopolysaccharide-induced vasomotor dysfunction in skeletal muscle in vivo
11. Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta
12. Development and clinical application of ELISA for human chymase
13. Increased chymase activity in internal thoracic artery of patients with hypercholesterolemia
14. Chymase inhibitor decrease aortic cholesterol deposition in high cholesterol-fed hamster
15. Rapid and specific conversion of precursor interleukin 1β (1L-1β) to an active IL-1 species by human mast cell chymase
16. 84 bond by mast cell chymase
17. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide
18. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein Al-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid
19. Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells
20. Angiotensin II formation in the intact human heart
21. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid: Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity
22. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart
23. Cardiac angiotensin II formation: The angiotensin-I converting enzyme and human chymase
24. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart
25. Chymase-dependent angiotensin II formation in human vascular tissue